Skip to main content
Clinical Trials/NCT02206217
NCT02206217
Completed
Not Applicable

The Clinical Trial of Myopia Control in Schoolchildren Using the Multi-segment (MS) Lens

The Hong Kong Polytechnic University1 site in 1 country183 target enrollmentAugust 2014
ConditionsMyopia

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Myopia
Sponsor
The Hong Kong Polytechnic University
Enrollment
183
Locations
1
Primary Endpoint
Cycloplegic Refraction Change in SER
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

The purpose of this study is to determine if the Multiple-Segment (MS) spectacle lens can slow myopia progression in Hong Kong schoolchildren.

MS lens is also called Defocus Incorporated Multiple Segments (DIMS) spectacle lens

Detailed Description

MS lens is a novel lens designed in attempt to slow myopia progression. It is a multifocal spectacle lens which corrects distance refractive error and at the same time produces myopic defocus images on the retina for all distances. The myopic defocus aims at slowing down myopia progression. The purpose of this study is to investigate if the MS lens can slow myopia progression in Hong Kong Chinese schoolchildren. The subjects will be randomly assigned to either treatment group (wear MS lenses) or control group (wear ordinary single vision lenses). Their cycloplegic refraction and axial length will be monitored every six months over 2 years. The changes in refractive errors and axial length in two groups will be compared.

Registry
clinicaltrials.gov
Start Date
August 2014
End Date
July 2017
Last Updated
5 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Carly Lam

Professor

The Hong Kong Polytechnic University

Eligibility Criteria

Inclusion Criteria

  • Age at enrolment: 8-13 year
  • Spherical equivalent refractions (SER): -1.00 to -5.00 Dioptres (D)
  • Astigmatism and anisometropia of 1.50 D or less
  • Spectacle corrected monocular logMAR visual acuity: 0 or better
  • Parents' understanding and acceptance of random allocation of grouping

Exclusion Criteria

  • any ocular and systemic abnormalities might affect visual functions or refractive development
  • prior treatment of myopic control, e.g. drugs, orthokeratology, progressive addition lenses, bifocal lenses, drugs (e.g. atropine), etc.

Outcomes

Primary Outcomes

Cycloplegic Refraction Change in SER

Time Frame: Baseline and 2 years

Change in cycloplegic SER (in diopter) that was measured using Shin-Nippon NVision-K 5001 autorefractor.

Secondary Outcomes

  • Axial Length(Baseline and 2 years)

Study Sites (1)

Loading locations...

Similar Trials